<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"><html xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>1743-422X-3-55.fm</title>
<meta name="Author" content="petere"/>
<meta name="Creator" content="FrameMaker 7.0"/>
<meta name="Producer" content="Acrobat Distiller 7.0 (Windows)"/>
<meta name="CreationDate" content=""/>
</head>
<body>
<pre>
Virology Journal

BioMed Central

Open Access

Research

Reemergence of dengue virus type-3 (subtype-III) in India:
Implications for increased incidence of DHF & DSS
Paban Kumar Dash1, Man Mohan Parida1, Parag Saxena1, Ajay Abhyankar1,
CP Singh2, KN Tewari2, Asha Mukul Jana1, K Sekhar1 and PV
Lakshmana Rao*1
Address: 1Division of Virology, Defence R&D Establishment, Jhansi Road, Gwalior- 474002, MP, India and 2Municipal Corporation, Delhi110001, India
Email: Paban Kumar Dash - pabandash@rediffmail.com; Man Mohan Parida - paridamm@rediffmail.com;
Parag Saxena - paragsaxena_viro@rediffmail.com; Ajay Abhyankar - abhyankarajay@rediffmail.com; CP Singh - cps_mcd@rediffmail.com;
KN Tewari - knt_mcd@rediffmail.com; Asha Mukul Jana - amjana@rediffmail.com; K Sekhar - drde@sancharnet.in; PV
Lakshmana Rao* - pvlrao@rediffmail.com
* Corresponding author

Published: 06 July 2006
Virology Journal 2006, 3:55

doi:10.1186/1743-422X-3-55

Received: 24 January 2006
Accepted: 06 July 2006

This article is available from: http://www.virologyj.com/content/3/1/55
© 2006 Dash et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract
Background: Dengue virus infection has recently taken endemic proportion in India implicating
all the four known dengue serotypes. There was a major dengue outbreak in northern India
including Delhi in October- December, 2003 and again in 2004. We have carried out a detailed
investigation of the 2004 outbreak by Serosurveillance, RT-PCR, nested PCR, virus isolation and
genotyping. We also report the molecular epidemiological investigation of these outbreaks.
Results: The serological investigation of 162 suspected serum samples using an in-house dengue
dipstick ELISA revealed 11%-IgM, 51%-IgG and 38%-both IgM and IgG antibody positivity. The RTPCR analysis revealed presence of dengue RNA in 17 samples. Further subtyping and genotyping
by nested PCR and nucleotide sequencing of C-prM gene junction revealed the association of
subtype III of dengue virus type 3 in the outbreak.
Conclusion: The sudden shifting and dominance of the dengue virus serotype-3 (subtype III)
replacing the earlier circulating serotype-2 (subtype IV) is a point of major concern and may be
attributed to increased incidence of DHF and DSS in India.

Background
Dengue virus infection is now recognized as one of the
most important mosquito borne human infections of 21st
century. The global incidences of the dengue infection has
now increased enormously and an estimated 50–100 million cases of dengue infections are now reported annually
from more than 100 tropical and sub tropical countries of
the world [1]. Dengue is caused by four antigenically dis-

tinct viruses designated as dengue virus type 1–4 (DEN 1–
4), belonging to genus Flavivirus of family Flaviviridae. The
genome of dengue virus consists of a single stranded, non
segmented, positive sense ribonucleic acid (RNA) of
approximately 10.7 kb in length [2]. All the four serotypes
of dengue viruses are primarily transmitted by Aedes
aegypti .Infection with any one of these serotypes generally
leads to a mild, self limiting febrile illness (classical den-

Page 1 of 10
(page number not for citation purposes)

Virology Journal 2006, 3:55

gue fever (DF)). However, in few cases DF also leads to
severe life threatening dengue hemorrhagic fever (DHF)
and dengue shock syndrome (DSS). Several hypotheses,
like antibody dependent enhancement (ADE) in heterotypic secondary dengue infections, involvement of a virulent viral genotype, and host factors have been suggested
to explain the mechanism of pathogenesis of DHF and
DSS [3].
The number of DHF and DSS cases have increased enormously in the last two decades in India and DEN-2 has
been implicated as the causative agent in most of these
outbreaks [4,5]. It is widely reported that DEN-2 is circulating predominantly in most parts of India and involvement of other serotypes in major dengue outbreaks are
not reported since 1995. However, surprisingly, a major
epidemic struck in many parts of northern India including
National Capital Delhi and Gwalior in Madhya Pradesh
in 2003, in which DEN-3 virus was implicated as the
major serotype [6,7]. Again dengue cases were reported
during September – October, 2004 in Delhi.
In the present study, we report the serological, virological
and molecular investigation of the 2004 Dengue outbreak. We also report the molecular epidemiological
investigation of the 2003 and 2004 Delhi outbreaks based
on the nucleotide sequence analysis of C-prM gene junction.

Results
Outbreak
An outbreak of febrile illness was reported in Delhi, India,
during September- October 2004. The trend of the epidemic indicated the maximum number of cases was
reported from the 1st to 3rd week of October. The clinical
history revealed that all the patients had suffered from
fever ranging from 38.5° to 40°C. Most of the prominent
clinical symptoms include headache (75%), myalgia
(66%), rash (48%), vomiting (42%), conjunctival hemorrhage (38%), epistaxis (17%) and melena (5%). The
platelet count varies from 18000 – 2.8 lakhs (Mean
62,000). The epidemic affected males and females at a
ratio of 2.6:1. Majority (52.5%) of the patients were found
belong to the age group more than 25 years. The detail distribution of the disease in terms of the age and sex of the
patients is listed in Table 1.
Serology
The serological analysis revealed that a total of 141 samples (87%) are positive for the presence of dengue specific
antibodies. Out of these antibody positive cases, 16
(11%) were found positive for IgM, 72 (51%) for IgG and
53 (38%) had both IgM and IgG antibodies.

http://www.virologyj.com/content/3/1/55

Table 1: Age and sex distribution of dengue suspected patients in
Delhi during September-October, 2004

Age (Year)

No. of patients
Male

0–5
6–10
11–15
16–20
21–25
>25

Female

Total

4 (3.4%)
4(3.4%)
8(5%)
15 (9.25%)
23(14.1%)
63(39%)

3(2%)
7(4.32%)
5(3.08%)
8(5%)
22(13.5%)

7
4
15
20
31
85

RT-PCR
A total of 17 (10%) samples were found positive for the
presence of dengue virus specific nucleic acid as demonstrated by the presence of dengue complex specific 511 bp
amplicon in 2% agarose gel.
Isolation
Isolation of virus was attempted from all the RT-PCR positive samples in C6/36 cells. A total of four dengue viruses
were isolated from these samples. The isolation was confirmed at each passage level by RT-PCR.
Typing of viruses
The serotype of the isolated virus, as well as viruses
directly from serum samples was determined by nested
PCR using serotype specific primers. The result indicated
that all the 17 samples were positive for DEN-3 specific
RNA.
Nucleotide sequence analysis
The nucleotide sequence of the C-prM gene junction (454
bp; excluding the primer sequence) of the nine representative dengue viruses and one NIV reference DEN-3 virus
(isolated in Philippines in 1957) were determined in the
present study. Detailed descriptions of these viruses were
given in Table 2. These sequences were compared with
eighteen other geographically diverse dengue-3 isolates
(Table 3). All these sequences were aligned with the
homologous regions (nt 160–613) of prototype DEN-3
isolate (H-87, isolated in 1956 in Philippines; designated
as PHIL-56 in this manuscript) (Fig. 1 and 2 ). The alignment did not reveal any base insertion or deletion in this
region. This region was found to be AT rich and the AT
composition of the nine Indian DEN-3 viruses, sequenced
in this study varied from 52.42–53.3 % (avg. 52.92 %).
On comparison to PHIL-56 (H-87), majority of mutations
were found to be silent. Majority of mutations were found
to be of transition type. The ratio of transition to transversion was found to be 15:1. The deduced amino acids were
also aligned following the nucleotide alignment pattern
(Fig 3). Majority of the amino acid changes are found to
be conservative type except a very few like M-I (at position

Page 2 of 10
(page number not for citation purposes)

Virology Journal 2006, 3:55

http://www.virologyj.com/content/3/1/55

Table 2: Description of dengue type-3 viruses sequenced in this study

Sl. No

Virus ID. No

Date of collection of sample

Clinical Status

Age (Year)

Sex

Passage History

GenBank Accession No

1
2
3
4
5
6
7
8
9
10

DEL-12
GWL-25
GWL-60
DEL-61
DEL-75
DEL-135
DEL-139
DEL-170
DEL-171
PHIL-57b

24-10-2003
03-11-2003
26-11-2003
29-09-2004
24-09-2004
16-10-2004
16-10-2004
22-10-2004
22-10-2004
IU

IUa
DF
DHF
DHF
DF
DHF
DF
DHF
DF
IUa

IUa
12
9
22
11
24
22
30
22
IUa

IUa
F
M
F
F
M
F
F
F
IUa

NIL
NIL
NIL
NIL
NIL
NIL
NIL
NIL
NIL
SMc (P-58)

AY770513
AY770511
AY770512
DQ323037
DQ323038
DQ323039
DQ323040
DQ323041
DQ323042
NSd

IUa: Information Unknown, b : NIV Reference Strain
SMc : Suckling mouse, NSd: Not submitted

108) and T-A (at position 112). On comparison of C-prM
genomic region, it has been found that all the DEN-3
viruses, sequenced in this study, were very closely related
(more than 99%), except the GWL-60, which revealed
around 97 % nucleotide sequence identity. However,
these Indian DEN-3 viruses revealed an average of 95.3%
sequence identity with prototype DEN-3 isolate (H-87).
When compared with another Indian DEN-3 virus (isolated in 1984), the nucleotide and amino acid sequence
homology was found to be 99.84 and 100 % respectively.
Phylogenetic analysis
Two different dendrograms were drawn based on the pairwise comparison of nucleotide sequence of partial prM
sequence (nt. position 437–613) (Fig 4) and C-prM gene
junction (nt. position from 179 to 613, corresponding to
PHIL-56) (Fig 5). The dendrogram based on prM clearly

revealed four different subtypes of DEN-3 viruses. All the
2003 Indian isolates were grouped into subtype III, along
with another Indian DEN-3 virus, isolated in 1984, and
large number of isolates recovered from various parts of
world, including Asia, Pacific Islands and South American
countries. The prototype H-87 (PHIL-56) was found to
belong to subtype I, along with two more isolates from
Philippines (1957 & 1983) and one each from Indonesia
(1990) and Fiji (1992). Two isolates from Thailand (isolated in 1962 and 1973) were found to belong to subtype
II, where as two isolates (TAHI-65 and PUER-77) were
found to belong to subtype IV.
The dendrogram based on the 435 nucleotide sequence of
C-prM gene junction also clearly distinguished the two
different genotypes (I and III). All the 2003 and 2004
Indian viruses except GWL-60 form a close branch along

Table 3: Description of global dengue-3 viruses used for comparison of genome sequence

Sl. No

Virus ID. No

Year of isolation

Country of origin

Genotype

GenBank Accession No

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18

H-87
A68.AP-2
85–159
29472
5987
CH53489
1416
BR-74886
GUATE97-5
GUATE98-5
H/IMTSSA/1706
H/IMTSSA/2012
Mozambique85
SOMO79
D1440
K1
65
1340

1956
1983
1985
1992
1962
1973
1984
2002
1997
1998
2000
2001
1985
1993
1984
1998
1965
1977

Philippines
Philippines
Indonesia
Fiji
Thailand
Thailand
India
Brazil
Guatemala
Guatemala
Martinique
Martinique
Mozambique
Somalia
Sri Lanka
Sri Lanka
Tahiti
Puerto Rico

I
I
I
I
II
II
III
III
III
III
III
III
III
III
III
III
IV
IV

M93130
L11432
L11428
L11422
L11440
L11626
L11424
AY679147
AB038473
AB038478
AY099339
AY099340
AY665402
AF547240
AF547229
AF547243
L11439
L11434

Page 3 of 10
(page number not for citation purposes)

Virology Journal 2006, 3:55

http://www.virologyj.com/content/3/1/55

160
PHIL-56 (H-87)
PHIL- 57
INDI-03 (DEL 12)
INDI-03 (GWL 25)
INDI-03 (GWL 60)
INDI-04 (DEL 61)
INDI-04 (DEL 75)
INDI-04 (DEL 135)
INDI-04 (DEL 139)
INDI-04 (DEL 170)
INDI-04 (DEL 171)
INDI-84
SRIL-84
SRIL-98
SOMA-93
BRAZ-02
GUET-97
GUET-98
MART-00
MART-01
MOZA-85
THAI-62
THAI-73
FIJI-92
INDO-85
PHIL-83
PUER-77
TAHI-65

T
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
-

GT
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
- - - - . .
. .
. .
. .
. .
- - - - - - - - -

169
10
GT
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
- - - - . .
. .
. .
. .
. .
- - - - - - - - -

CAA CT
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
- - - - - - - - - - - - - - - - . . . . .
. . . . .
. . . . .
. . . . .
. . . . .
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

240
PHIL-56 (H-87)
PHIL- 57
INDI-03 (DEL 12)
INDI-03 (GWL 25)
INDI-03 (GWL 60)
INDI-04 (DEL 61)
INDI-04 (DEL 75)
INDI-04 (DEL 135)
INDI-04 (DEL 139)
INDI-04 (DEL 170)
INDI-04 (DEL 171)
INDI-84
SRIL-84
SRIL-98
SOMA-93
BRAZ-02
GUET-97
GUET-98
MART-00
MART-01
MOZA-85
THAI-62
THAI-73
FIJI-92
INDO-85
PHIL-83
PUER-77
TAHI-65

C GT
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
- - . . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
- - - - - - - - - - - - - - -

C A C A GT
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
- - - - - - - - - - .
- - - - - .
- - - - - .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
- . . . . .
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

249
90
T
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
-

TAT
. . .
C. .
C. .
C. .
C. .
C. .
C. .
C. .
C. .
C. .
- - C. .
C. .
C. .
C. .
C. .
C. .
C. .
C. .
C. .
- - - - - - - - - - - - - - -

A GC T T
. . . . .
. . . C.
. . . C.
. . . . .
. . . C.
. . . C.
. . . C.
. . . C.
. . . C.
. . . C.
- - - - . . . . .
. . . . .
. . . C.
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
- - - - - - - - - - - - - - - - - - - - - - - - - - - - -

320
PHIL-56 (H-87)
PHIL- 57
INDI-03 (DEL 12)
INDI-03 (GWL 25)
INDI-03 (GWL 60)
INDI-04 (DEL 61)
INDI-04 (DEL 75)
INDI-04 (DEL 135)
INDI-04 (DEL 139)
INDI-04 (DEL 170)
INDI-04 (DEL 171)
INDI-84
SRIL-84
SRIL-98
SOMA-93
BRAZ-02
GUET-97
GUET-98
MART-00
MART-01
MOZA-85
THAI-62
THAI-73
FIJI-92
INDO-85
PHIL-83
PUER-77
TAHI-65

179
20

GGA T
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
- - - - - - - - - - - - . . . .
. . . .
. . . .
. . . .
. . . .
- - - - - - - - - - - - - - - - - - - - - - - - -

GGGGC T A T
. . . . . . . .
. . . . . . . .
. . . . . C. .
. . . . . C. .
. . . . . C. .
. . . . . C. .
. . . . . C. .
. . . . . C. .
. . . . . C. .
. . . . . C. .
- - - - - - - A. . . . C. .
. . . . . C. .
. . . . . C. .
. . . . . C. .
. . . . . C. .
. . . . . C. .
. . . . . C. .
. . . . . C. .
. . . . . C. .
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

189
30

CCT
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
- - . . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
- - - - - - - - - - - - - - -

C A GA T
. . . . .
T. . . .
T. . . .
. . . . .
T. . . .
T. . . .
T. . . .
T. . . .
T. . . .
T. . . .
- - - - . . . . .
. . . . .
. . . . .
. . . . .
. . . . .
T. . . .
. . . . .
. . . . .
. . . . .
- - - - - - - - - - - - - - - - - - - - - - - - - - - - -

A A GGT
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
- - - - . . . . .
. . . . .
. . A. .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
- - - - - - - - - - - - - - - - - - - - - - - - - - - - -

T
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
-

CT
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
- . .
. .
. .
. .
. .
. .
. .
. .
. .
- - - - - - - -

C A A GA GGA T T
. . . . . . . . . .
. . . A. . . . . .
. . . A. . . . . .
. . . A. . . . C.
. . . A. . . . . .
. . . A. . . . . .
. . . A. . . . . .
. . . A. . . . . .
. . . A. . . . . .
. . . A. . . . . .
- - - - - - - - - . . . A. . . . C.
. . . A. . . . C.
. . . A. . . . C.
. . . A. . . . C.
. . . A. . . . C.
. . . A. . . . C.
. . . A. . . . C.
. . . A. . . . C.
. . . A. . . . C.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

269
110
T
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
-

T
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
-

CT
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
- . .
. .
. .
. .
. .
. .
. .
. .
. .
- - - - - - - -

A GCCA T
. . . . . .
G. . . . .
G. . . . .
. . . . . .
G. . . . .
G. . . . .
G. . . . .
G. . . . .
G. . . . .
G. . . . .
- - - - - . . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

339
180
CT T
. . .
. C.
. C.
. C.
. C.
. C.
. C.
. C.
. C.
. C.
- - . C.
. C.
. C.
. C.
. C.
. C.
. C.
. C.
. C.
- - - - - - - - - - - - - - -

199
40

GGC GA A GA GA T
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
- - - - - - - - - - . . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

259
100
T
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
-

329
170
T
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
-

T
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
-

A A A A GGC T
. . . . . . . .
G. . . . . . .
G. . . . . . .
G. . . . . . .
G. . . . . . .
G. . . . . . .
G. . . . . . .
G. . . . . . .
. . . . . . . .
G. . . . . . .
- - - - - - - . . . . . . . .
G. . . . . . .
G. . . . . . .
G. . . . . . .
G. . . . . . .
G. . . . . T .
G. . . . . . .
G. . . . . . .
G. . . . . . .
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

279
120

C A A GA A GGA GA T
. . . . . . . . . . . .
. . . . . . . . . . . .
. . . . . . . . . . . .
. . . . . . . . . . . .
. . . . . . . . . . . .
. . . . . . . . . . . .
. . . . . . . . . . . .
. . . . . . . . . . . .
. . . . . . . . . . . .
. . . . . . . . . . . .
- - - - - - - - - - - . . . . . . . . . . . .
. . . . . . . . . . . .
. . . . . G. . . . . .
. . . . . . . . . . . .
. . . . . . . . . . . .
. . . . . . . . . . . .
. . . . . . . . . . . .
. . . . . . . . . . . .
. . . . . . . . . . . .
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

359
200
CT
. .
T.
T.
. .
T.
T.
T.
T.
T.
T.
- . .
. .
. .
. .
. .
. .
. .
. .
. .
- - - - - - - -

CA AA CAT
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
- - - - - - . . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

219
60

GA A C GGC C A A GGA C C A A T
. . . . . . . . . . . . . . . . . .
. . . . . . . . . G. . . . . . . .
. . . . . . . . . G. . . . . . . .
. . . . . . . . . G. . . . . . . .
. . . . . . . . . G. . . . . . . .
. . . . . . . . . G. . . . . . . .
. . . . . . . . . G. . . . . . . .
. . . . . . . . . G. . . . . . . .
. . . . . . . . . G. . . . . . . .
. . . . . . . . . G. . . . . . . .
- - - - - - - - - - - - - - - - - . . . . . . . . . G. . . . . . . .
. . . . . . . . . G. . . . . . . .
A . . . . . . . . G. . . . . . . .
. . . . . . . . . G. . . . . . . .
. . . . . . . . . G. . . . . . . .
. . . . . . . . . G. . . . . . . .
. . . . . . . . . G. . . . . . . .
. . . . . . . . . G. . . . . . . .
. . . . . . . . . G. . . . . . . .
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

289
130

T C C A C C GA C A GC A GGA GT
. . . . . . . . . . . . . . . . . .
. . . . . . A. . . . . . . . . . .
. . . . . . A. . . . . . . . . . .
C. . . . . A. . . . . . . . . . .
. . . . . . A. . . . . . . . . . .
. . . . . . A. . . . . . . . . . .
. . . . . . A. . . . . . . . . . .
. . . . . . A. . . . . . . . . . .
. . . . . . A. . . . . . . . . . .
. . . . . . A. . . . . . . . . . .
- - - - - - - - - - - - - - - - - . . . . . . A. . . . . . . . . . .
. . . . . . A. . . . . . . . . . .
. . . . . . A. . . . . . . . . . .
. . . . . . A. . . . . . . . . . .
. . . . . . . . . . . . . . . . . .
. . . . . . A. . . . . . . . . . .
. . . . . . A. . . . . . . . . . .
. . . . . . A. . . . . . . . . . .
. . . . . . A. . . . . . . . . . .
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

349
190
T
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
-

209
50
GC T
. . .
. . .
. . .
. T.
. . .
. . .
. . .
. . .
. . .
. . .
- - . . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
- - - - - - - - - - - - - - -

CT
. .
T.
T.
. .
T.
T.
T.
T.
T.
T.
- T.
. .
. .
. .
. .
. .
. .
T.
. .
- - - - - - - -

299
140
T
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
-

GGC T A GA T
. . . . . . . .
. . . C. . . .
. . . C. . . .
. . . . . . . .
. . . C. . . .
. . . C. . . .
. . . C. . . .
. . . C. . . .
. . . C. . . .
. . . C. . . .
- - - - - - - . . . . . . . .
. . . . . . G.
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

369
210
GC T
. . .
. T.
. T.
. . .
. T.
. . .
. . .
. . .
. . .
. . .
- - . . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
- - - - - - - - - - - - - - -

GA GC A T
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
- - - - - . . . . . .
. . . . . .
A. . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

309
150

GGGGT A C C T T
. . . . . . . . . .
. . . . A. . . . .
. . . . A. . . . .
. . . . A. . . . .
. . . . A. . . . .
. . . . A. . . . .
. . . . A. . . . .
. . . . A. . . . .
. . . . A. . . . .
. . . . A. . . . .
- - - - - - - - - . . . . A. . . C.
. . . . A. . . . .
. . . . A. . . . .
. . . . A. . . . .
. . . . A. . . . .
. . . . A. . . . .
. . . . A. . . . .
. . . . A. . . . .
. . . . A. . . . .
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

379
220
TAT
. . .
A. .
A. .
A. .
A. .
A. .
A. .
A. .
A. .
A. .
- - A. .
A. .
A. .
A. .
A. .
A. .
A. .
A. .
A. .
- - - - - - - - - - - - - - -

229
70
GA A A T
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
- - - - . . . . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
- - - - - - - - - - - - - - - - - - - - - - - - - - - - -

239
80
T
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
-

GGT
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
- - . . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
- - - - - - - - - - - - - - -

TAT
. . .
C. .
C. .
. . .
C. .
C. .
C. .
C. .
C. .
C. .
- - . . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
- - - - - - - - - - - - - - -

319
160

T A A GA A GT
. . . . . . . .
C. . . . . . .
C. . . . . . .
C. . . . . . .
C. . . . . . .
C. . . . . . .
C. . . . . . .
C. . . . . . .
C. . . . . . .
C. . . . . . .
- - - - - - - C. . . . . . .
C. . . . . . .
C. . . . . . .
C. . . . . . .
C. . . . . . .
C. . . . . . .
C. . . . . . .
C. . . . . . .
C. . . . . . .
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

389
230

GG
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
- . .
. .
. .
. .
. .
. .
. .
. .
. .
- - - - - - - -

CG
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
- . .
. .
. .
. .
. .
. .
. .
. .
. .
- - - - - - - -

399
240

C A A C A A A C GGA A A A A GA C A T
. . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . G.
. . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . .
- - - - - - - - - - - - - - - - - - - . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . G. . . . . . .
. . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . .
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

C
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
-

Figure sequence alignment of C-prM gene junction [nucleotide 160–399 corresponding to the prototype DEN-3 virus (H87)]
Multiple1
Multiple sequence alignment of C-prM gene junction [nucleotide 160–399 corresponding to the prototype DEN-3 virus (H87)]. Dot (.) indicates nucleotide similarities with H-87. Dash (-) indicates sequence not available. Each strain is abbreviated
with first four letters of country of origin followed by last two digits of the year of isolation.

Page 4 of 10
(page number not for citation purposes)

Virology Journal 2006, 3:55

http://www.virologyj.com/content/3/1/55

400
PHIL-56 (H-87)
PHIL- 57
INDI-03 (DEL 12)
INDI-03 (GWL 25)
INDI-03 (GWL 60)
INDI-04 (DEL 61)
INDI-04 (DEL 75)
INDI-04 (DEL 135)
INDI-04 (DEL 139)
INDI-04 (DEL 170)
INDI-04 (DEL 171)
INDI-84
SRIL-84
SRIL-98
SOMA-93
BRAZ-02
GUET-97
GUET-98
MART-00
MART-01
MOZA-85
THAI-62
THAI-73
FIJI-92
INDO-85
PHIL-83
PUER-77
TAHI-65

GC T
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
- - . . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
- - - - - - - - - - - - - - -

409
250
CT
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
- . .
. .
. .
. .
. .
. .
. .
. .
. .
- - - - - - - -

GT
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
- . .
. .
. .
. .
. .
. .
. .
. .
. .
- - - - - - - -

CT
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
- . .
. .
. .
. .
. .
. .
. .
. .
. .
- - - - - - - -

480
PHIL-56 (H-87)
PHIL- 57
INDI-03 (DEL 12)
INDI-03 (GWL 25)
INDI-03 (GWL 60)
INDI-04 (DEL 61)
INDI-04 (DEL 75)
INDI-04 (DEL 135)
INDI-04 (DEL 139)
INDI-04 (DEL 170)
INDI-04 (DEL 171)
INDI-84
SRIL-84
SRIL-98
SOMA-93
BRAZ-02
GUET-97
GUET-98
MART-00
MART-01
MOZA-85
THAI-62
THAI-73
FIJI-92
INDO-85
PHIL-83
PUER-77
TAHI-65

GGA A GA A T
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .

560
PHIL-56 (H-87)
PHIL- 57
INDI-03 (DEL 12)
INDI-03 (GWL 25)
INDI-03 (GWL 60)
INDI-04 (DEL 61)
INDI-04 (DEL 75)
INDI-04 (DEL 135)
INDI-04 (DEL 139)
INDI-04 (DEL 170)
INDI-04 (DEL 171)
INDI-84
SRIL-84
SRIL-98
SOMA-93
BRAZ-02
GUET-97
GUET-98
MART-00
MART-01
MOZA-85
THAI-62
THAI-73
FIJI-92
INDO-85
PHIL-83
PUER-77
TAHI-65

GGA GA GA T
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . A. .
. . . . . A. .

CAT
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
- - . . .
. . .
. . .
. . .
. . .
. . .
T. .
. . .
. . .
- - - - - - - - - - - - - - -

419
260
GA T
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
- - . . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
- - - - - - - - - - - - - - -

489
330

GA T
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
- - . . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
- - - - - - - - - - - - - - -

GT
. .
A.
A.
A.
A.
A.
A.
A.
A.
A.
- A.
A.
A.
A.
A.
A.
A.
A.
A.
- - - - - - - -

T
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
-

499
340

GA A A GA GGA A A A T
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . T.
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . G. . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .

569
410
GT
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .

GT
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .

429
270

ACT
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .

579
420
GA T
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .

T
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
-

509
350
CCCT
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. T. .
. . . .
. . . .

GA C A C GGT
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . AA.
. . . . . A. .

T
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

T
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

T
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

T
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

GC T
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
- - . . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
- - - - - - - - - - - - - - -

T CCACT
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . T.
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
C. . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . T.
. . . . . .
. . . . . .
. . . . . .

519
360

ACA AAT
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. T. . . .
. . . . . .
. . . . . .

449
290

prM

T
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

T A A GA C A GC C T
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
C. . . . . . . . T .
. . . . . . . . . T.
C. . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
C. . . . . . . . . .
C. . . . . . . . . .

589
430
CACT
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .

439
280

C

A C C A GC A A C A C T
. . . . . . . . . . . .
G. . . . . . G. . . .
G. . . . . . G. . . .
G. . . . . . G. . . .
G. . . . . . G. . . .
G. . . . . . G. . . .
G. . . . . . G. . . .
G. . . . . . G. . . .
G. . . . . . G. . . .
G. . . . . . G. . . .
- - - - - - - - - - - G. . . . . . G. . . .
G. . . . . . G. . . .
G. . . . . . . . . . .
G. . . . . . G. . . .
G. . . . . . G. . . .
G. . . . . . G. . . .
G. . . . . . G. . . .
G. . . . . . G. . . .
G. . . . . . . . . . .
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

T
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

AACT
. . . .
G. . .
G. . .
G. . .
G. . .
G. . .
G. . .
G. . .
G. . .
G. . .
G. . .
G. . .
G. . .
G. . .
G. . .
G. . .
G. . .
G. . .
G. . .
G. . .
G. . .
G. . .
G. . .
G. . .
G. . .
G. . .
G. . .

T
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

459
300

C A C GA GA T
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . G. . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .

529
370
CT
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .

599
440
GC C C C C A C A T
. . . . . . . . . .
. . . . . . . . . .
. . . . . . . . . .
. . . . . . . . . .
. . . . . . . . . .
. . . . . . . . . .
. . . . . . . . . .
. . . . . . . . . .
. . . . . . . . . .
. . . . . . . . . .
. . . . . . . . . .
. . . . . . . T. .
. . . . . . . . . .
. . . . . . . . . .
. . . . . . . . . .
. . . . . . . . . .
. . . . . . . . . .
. . . . . . . . . .
. . . . . . . . . .
. . . . . . . . . .
. . . . . . . . . .
. . . . . . . . . .
. . . . . . T. . .
. . . . . . T. . .
. . . . . . T. . .
. T. . . . . . . .
. . . . . . . . . .

469
310

GGA GA GC C GC GC A T
. . . . . . . . . . . . . .
. . . . . . . . . . . . . .
. . . . . . . . . . . . . .
. . . . . . . . T. . . . .
. . . . . . . . . . . . . .
. . . . . . . . . . . . . .
. . . . . . . . . . . . . .
. . . . . . . . . . . . . .
. . . . . . . . . . . . . .
. . . . . . . . . . . . . .
. . . . . . . . . . . . . .
. . . . . . . . . . . . . .
. . . . . . . . . . . T. .
. . . . . . . . . . . . . .
. . . . . . . . . . . . . .
. . . . . . . . . . . . . .
. . . . . . . . . . . . . .
. . . . . . . . . . . . . .
. . . . . . . . . . . . . .
. . . . . . . . . . . . . .
. . . . . . . . . . . . . .
. . . . . . . . . . . . . .
. . . . . . . . . . . . . .
. . . . . . . . . . . . . .
. . . . . . . . . . . . . .
. . . . . . . . . . . . . .
. . . . . . . . . . . . . .

539
380

GGA A T C A A C A T
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . T. . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . T. . . . .
. . . . . T. . . . .
. . . . . . . . . . .
. . . . . T. . . . .
. . . . . T. . . . .
. . . . . T. . . . .
. . . . . T. . . . .
. . . . . T. . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . C. . . . . .
. . . . C. . . . . .

GT
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .

GC A C A C T
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .

479
320
GA T
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .

T
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

GT
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .

549
390
CAT
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
T. .
T. .

A GC C A T
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .

GG
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .

559
400
GGA T T
. . . . .
. . . C.
. . . C.
. . . C.
. . . C.
. . . C.
. . . C.
. . . C.
. . . C.
. . . C.
. . . C.
. . . C.
. . . C.
. . . C.
. . . C.
. . . C.
. . . C.
. . . C.
. . . C.
. . . C.
. . . . .
. . . C.
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .

T
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

G
.
.
.
.
.
.
.
.
.
.
.
.
.
A
.
.
.
.
.
.
.
.
.
.
.
.
.

609
450
T A C C GA A GT
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. G. . . . . . .
. G. . . . . . .
. . . T. . . . .
. . . T. . . . .
. . . T. . . . .
C. . . . . . . .
C. . . . . . . .

G
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

Figure 2
Multiple sequence alignment of C-prM gene junction [nucleotide 400-613 corresponding to the prototype DEN-3 virus (H-87)]
Multiple sequence alignment of C-prM gene junction [nucleotide 400-613 corresponding to the prototype DEN-3 virus (H87)]. Dot (.) indicates nucleotide similarities with H-87. Dash (-) indicates sequence not available. Each strain is abbreviated
with first four letters of country of origin followed by last two digits of the year of isolation.

Page 5 of 10
(page number not for citation purposes)

Virology Journal 2006, 3:55

23

PHIL-56 (H-87)
PHIL- 57
INDI-03 (DEL 12)
INDI-03 (GWL 25)
INDI-03 (GWL 60)
INDI-04 (DEL 61)
INDI-04 (DEL 75)
INDI-04 (DEL 135)
INDI-04 (DEL 139)
INDI-04 (DEL 170)
INDI-04 (DEL 171)
INDI-84
SRIL-84
SRIL-98
SOMA-93
BRAZ-02
GUET-97
GUET-98
MART-00
MART-01
MOZA-85
THAI-62
THAI-73
FIJI-92
INDO-85
PHIL-83
PUER-77
TAHI-65

32
10

42
20

52
30

V S T GS QL A K RF S RGL L NGQGP MK L V MA F I
. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . K. . . . . . . . . . . . . . . .
. . . . . . . . . . . . K. . . . . . . . . . . . . . . .
. . . . . . . . . . . . K. . . . . . . . . . . . . . . .
. . . . . . . . . . . . K. . . . . . . . . . . . . . . .
. . . . . . . . . . . . K. . . . . . . . . . . . . . . .
. . . . . . . . . . . . K. . . . . . . . . . . . . . . .
. . . . . . . . . . . . K. . . . . . . . . . . . . . . .
. . . . . . . . . . . . K. . . . . . . . . . . . . . . .
. . . . . . . . . . . . K. . . . . . . . . . . . . . . .
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - . . . . . . K. . . . . . . . . . . . . . . .
- - - - - - . . . . . . K. . . . . . . . . . . . . . . .
- - - - - - . . . . . . K. . . . . . . . . . . . . . . .
. . . . . . . . . . . . K. . . . . . . . . . . . . . . .
. . . . . . . . . . . . K. . . . . . . . . . . . . . . .
. . . . . . . . . . . . K. . . . . . . . . . . . . . . .
. . . . . . . . . . . . K. . . . . . . . . . . . . . . .
. . . . . . . . . . . . K. . . . . . . . . . . . . . . .
- - - - - . . . . . . . K. . . . . . . . . . . . . . . .
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 103

PHIL-56 (H-87)
PHIL- 57
INDI-03 (DEL 12)
INDI-03 (GWL 25)
INDI-03 (GWL 60)
INDI-04 (DEL 61)
INDI-04 (DEL 75)
INDI-04 (DEL 135)
INDI-04 (DEL 139)
INDI-04 (DEL 170)
INDI-04 (DEL 171)
INDI-84
SRIL-84
SRIL-98
SOMA-93
BRAZ-02
GUET-97
GUET-98
MART-00
MART-01
MOZA-85
THAI-62
THAI-73
FIJI-92
INDO-85
PHIL-83
PUER-77
TAHI-65

http://www.virologyj.com/content/3/1/55

113
90

C

prM

123
100

L CL MMML P A T L A F HL T S RDGE P RMI
. . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . I . . . A. . . . . . . . . . . . . . .
. . . . . I . . . A. . . . . . . . . . . . . . .
. . . . . I . . . A. . . . . . . . . . . . . . .
. . . . . I . . . A. . . . . . . . . . . . . . .
. . . . . I . . . A. . . . . . . . . . . . . . .
. . . . . I . . . A. . . . . . . . . . . . . . .
. . . . . I . . . A. . . . . . . . . . . . . . .
. . . . . I . . . A. . . . . . . . . . . . . . .
. . . . . I . . . A. . . . . . . . . . . . . . .
- - - - - - - - - - - - . . . . . . . . . . . . .
. . . . . I . . . A. . . . . . . . . . . . . . .
. . . . . I . . . A. . . . . . . . . . . . . . .
. . . . . I . . . . . . . . . . . . . . . . . . .
. . . . . I . . . A. . . . . . . . . . . . . . .
. . . . . I . . . A. . S. . . . . . . . . . . .
. . . . . I . . . A. . . . . . . . . . . . . . .
. . . . . I . . . A. . . . . . . . . . . . . . .
. . . . . I . . . A. . . . . . . . . . . . . . .
. . . . . I . . . . . . . . . . . . . . . . . . .
- - - - - - - - - - - - . . . . . . . . . . . . .
- - - - - - - - - - - - . . . . . . . . . . . . .
- - - - - - - - - - - - . . . . . . . . . . . . .
- - - - - - - - - - - - . . . . . . . . . . . . .
- - - - - - - - - - - - . . . . . . . . . . . . .
- - - - - - - - - - - - . . . . . . . . . . . . .
- - - - - - - - - - - - . . . . . . . . . . . . .

A F L RF L A I
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
- - - - - - - . . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
. . . . . . . .
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

133
110

62
40

72
50

P P T A GV L A RWGT F K K S GA I
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
- - - - - - - - - - - - - - - - - - . . . . . . . . . . . . L . . . R. .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 143
120

V GK NE RGK S L L F K T A S GI NMCT L I
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . N. . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . T. . . . . .
. . . . . . . . . . . . . . . . . T. . . . . .

153
130

82
60

K V L K GF K K E I
. . . . . . . . . .
. . . . . . . . . .
. . . . . . . . . .
. . . . . . . . . .
. . . . . . . . . .
. . . . . . . . . .
. . . . . . . . . .
. . . . . . . . . .
. . . . . . . . . .
. . . . . . . . . .
- - - - - - - - - . . . . . . . . . .
. . . . . . . . . .
. . . . . . . R. .
. . . . . . . . . .
. . . . . . . . . .
. . . . . . . . . .
. . . . . . . . . .
. . . . . . . . . .
. . . . . . . . . .
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

92
70

102
80

S NML S I
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
- - - - - . . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

163
140

A MDL GE MCDDT V T Y K CP HI
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . L.
. . . . . . . . . . . . . . . . . L.
. . . . . . . . . . . . . . . . . L.
. . . . . . . . . . . I . . . . . . .
. . . . . . . . . . . . . . . . . . .

I
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
-

NK RK K T S
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
- - - - - - . . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

173
150

T EV
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
A. .
A. .
. . .
. . .
. . .
. . .
. . .

Figure 3
virus (H-87)
Multiple sequence alignment of deduced amino acid (aa) corresponding to the aa 23 to 173 of the ORF of prototype DEN-3
Multiple sequence alignment of deduced amino acid (aa) corresponding to the aa 23 to 173 of the ORF of prototype DEN-3
virus (H-87). Dot (.) indicates amino acid similarities with H-87. Dash (-) indicates sequence not available. Each strain is abbreviated with first four letters of country of origin followed by last two digits of the year of isolation.

Page 6 of 10
(page number not for citation purposes)

Virology Journal 2006, 3:55

http://www.virologyj.com/content/3/1/55

SOMA-93

INDI-03 (GWL 25)

SRIL-98

64

INDI-04 (DEL 61)

GUET-97

INDI- 03 (DEL 12)

INDI-03 (GWL 60)

INDI 04 (DEL 135)

MART-00

INDI-04 (DEL 171)

64 GUET-98
MOZA-85

INDI 04 (DEL 139)
97

MART-01

INDI 04 (DEL 75)

30

INDI 04 (DEL 170)

BRAZ-02

SRIL-84

III

INDI-04 (DEL 61)

BRAZ-02

INDI-04 (DEL 139)

SOMA-93

55

INDI-04 (DEL 170)

MOZA-85

INDI-04 (DEL 75)

MART-01

SRIL-84

III
Post DHF era

GUET-97

INDI-84

GUET-98

INDI-04 (DEL 171)

43

MART-00

INDI-03 (GWL 25)

INDI-03 (GWL 60)

INDI- 03 (DEL 12)

SRIL-98

INDI-04 (DEL 135)
THAI-62

53

III
Pre DHF era

THAI-73

100

II

PHIL-56 (H-87)

I

PHIL- 57

63 PHIL-57
PHIL-56

0 .0 0 5
0.005 nt. substitutions/site

FIJI-92

57

I

PHIL-83
INDO-85
PUER-77

99

IV

TAHI-65
0 .0 0 5

0.005 nt. substitutions/site

Figure 4
partial joining method based on viruses generated by Neighbour - prM gene
Phylogenetic tree among denguethe nucleotide sequence of
Phylogenetic tree among dengue viruses generated by Neighbour - joining method based on the nucleotide sequence of
partial prM gene. Each strain is abbreviated with first four letters of country of origin followed by last two digits of the
year of isolation. Bootstrap values are indicated at the major
branch points.

with SRIL-84; where as, GWL-60 forms a branch with
SRIL-98 and GUET-98 (Fig. 5).

Figure 5 - joining method based viruses generated
sequence of C-prM gene junction on the nucleotide by
Neighbour
Phylogenetic tree among dengue-3
Phylogenetic tree among dengue-3 viruses generated by
Neighbour - joining method based on the nucleotide
sequence of C-prM gene junction. Each strain is abbreviated
with first four letters of country of origin followed by last
two digits of the year of isolation. Bootstrap values are indicated at the major branch points. .

tors become unfavorable for virus transmission. During
this outbreak it has been observed that majority of the
patients belonged to age group of > 25 years. However, till
date, children and adolescents were recognized as the primary victim of dengue infection [8]. The appearance of
dengue primarily among higher age group during this outbreak, suggests the shifting trend towards higher age
group. This trend needs to be carefully monitored during
ensuing years, as, this can play vital role in planning the
control measures.

Discussion
Dengue is now emerging as the most important arboviral
infection in most parts of south east Asia including India.
In the past, the larger and severe outbreaks in India were
mostly caused by dengue virus type-2. However, the investigation of 2003 dengue outbreak in northern India (carried out by us) revealed the involvement of DEN-3 [6] and
was also in agreement with another study [7]. Again during the month of September in 2004, dengue reappeared
in Delhi and its adjoining areas. Like previous outbreaks,
this also struck following the monsoon season, when the
climatic factors (temperature and humidity) remained
conducive for Aedes breeding. The post monsoon dengue
outbreak is a regular feature of dengue activity in Indian
subcontinent [5-7]. This outbreak was subsided in
November upon arrival of winter, when the climatic fac-

The routine laboratory diagnosis of dengue virus infection
is primarily achieved by the isolation of virus, detection of
IgM/IgG antibodies by serodiagnosis and/or molecular
detection by the demonstration of viral RNA by RT-PCR
[9,10]. In the present study, we screened all the serum
samples for the presence of IgM and IgG antibodies by an
in house developed Dipstick ELISA assay. This test has
been extensively evaluated with field sera collected from
different parts of India and can discriminate primary and
secondary dengue infection effectively [6,11]. The results
of dipstick ELISA assay also supports the dengue viral etiology of the present outbreak. The presence of only IgG
antibodies in the majority (51%) of the patients revealed
that they were suffering from secondary dengue infection.
This is quite expected, as northern India, particularly

Page 7 of 10
(page number not for citation purposes)

Virology Journal 2006, 3:55

Delhi is endemic and has witnessed a number of large
dengue epidemics in the past decade [4,6,7].
RT-PCR is one of the most important confirmatory test,
employed to confirm dengue infection. However, it is
only positive when sample is collected during the viraemic phase of the patient (preferably within first five days
of onset of symptoms). In the present study, the identification of only 17 samples as dengue positive by RT-PCR,
may be due to the fact that most of the patients were presented to the hospitals in the post-viremic phase. Further
the lower rate of virus isolation may be attributed to the
absence of live virus in the sample. This may be due to
failure in maintenance of cold chain resulting in inactivation of virus. All the isolation was confirmed and identified by RT-PCR and nested PCR. Isolation and
identification of virus from the clinical sample is considered the gold standard and gives a confirmatory diagnosis
without any ambiguity [9,12].
Further, we have carried out the molecular epidemiology
and genotyping study of the DEN-3 viruses, implicated as
the causative agent of this outbreak. We have studied the
sequence of these dengue viruses, directly from patient
serum sample, as recently advocated by several researchers
[13,14]. Various genomic regions of dengue viruses have
been selected for molecular phylogenetic analysis [14-17].
However, we have selected the C-prM gene junction as it
also harbours epidemiologically important sequence
information. In addition, it provides an economic alternative, since a single set of primer pair could be used for
amplification and sequencing of any of the four serotype
of dengue virus. Based on C-prM sequence we have earlier
reported the circulation of genotype IV of DEN -2 in
northern India [14].
On comparison of the sequence, it was found that all the
Indian sequences were very closely related. It was found
that the outbreak over fairly large areas of two provinces
(Delhi and Madhya Pradesh, more than 300 km apart)
were caused by the same type of DEN-3 virus. This indicates that the current virus is easily transmitted in human
and mosquitoes and can adapt to a newer area efficiently.
We have drawn two different dendrograms to study the
evolutionary relationship of Indian DEN-3 isolates, due
to absence of sequence of capsid gene of any of the DEN3 viruses belonging to subtype II and IV. One phylogenetic tree was drawn based on the 177 nucleotide
sequence of partial prM gene, classified all the 28 DEN-3
viruses, analysed in this study into respective subtypes, as
designated in the classic paper of Lanciotti [16]. All the
Indian isolates were found to belong to subtype III along
with another Indian strain of 1984 and a large number of
geographically diverse strains. The dendrogram based on
the 435 nucleotide sequence of C-prM gene junction also

http://www.virologyj.com/content/3/1/55

clearly distinguished the two different subtypes (I and III).
All the 2003 and 2004 Indian viruses, except GWL-60
were found to be very closely related and form a close
branch along with SRIL-84; where as, GWL-60 form a
close branch with SRIL-98 and GUET-98. In an earlier
study, based on BLAST search, the DEN-3 viruses from
2003 Delhi outbreak, revealed close genomic homology
with GUET-98 [7]. The critical examination of the branching pattern revealed that though all the Indian DEN-3
viruses are closely related to SRIL-84, however they are following a different evolutionary pattern, away from the
SRIL-84. It has earlier been reported that SRIL-84 was isolated prior to emergence of DHF in Sri Lanka, where as
SRIL-98 was isolated in post DHF era [18].
The dendrogram and sequence analysis clearly revealed
that the subtype III of DEN-3 viruses are circulating
through out the world, where as other subtypes are localized to a particular small geographical area. This indicates
the higher potential of subtype III to spread, adapt and
dominate in geographically diverse areas of the world.
This subtype has also been implicated in major dengue/
DHF epidemic from several parts of Asia, Africa and Americas; and has the potential to cause a trans-national dengue pandemic [18].
Though all the four serotypes of dengue viruses were isolated from different parts of India, DEN-2 was considered
as the predominant serotype circulating in northern India
[4-7]. DEN-3 associated outbreak was last reported in
India in 1994 [19]. However, DEN-3 has been reported as
the etiology of the first major DHF outbreak in neighboring Bangladesh in 2001 [20] and also implicated in various outbreaks in Sri Lanka in recent past [18,21]. The
identification of the subtype III of dengue-3 from the
present outbreak in northern India in 2003 and its continued dominance again in 2004 indicates the resurgence of
dengue-3 in a dominant form. The emergence of a newer
dengue serotype after an interval always leads to a major
outbreak, which is a matter of great concern from public
health prospective [22].

Conclusion
This study confirms that the major dengue outbreak in
northern India in 2003 and 2004 was caused by dengue
virus type-3 (subtype III). The reemergence of highly fatal
subtype III of DEN-3 in a dominant form, replacing the
earlier circulating subtype IV of DEN-2 in India is a matter
of great concern. Detailed and continuous epidemiological surveillance is warranted to monitor the incursion and
spread of dengue viruses, which will help to undertake
effective control and management strategies at the earliest.

Page 8 of 10
(page number not for citation purposes)

Virology Journal 2006, 3:55

Methods
The outbreak
An outbreak of febrile illness was reported in Delhi, India,
during September-October, 2004. A total of 162 blood
samples from clinically suspected dengue patients were
collected from Delhi during this period. In addition, three
viraemic blood samples collected from Delhi and Gwalior
during October – December, 2003 [6] were also used in
this study for genetic analysis. (Informed consent from all
the patients and/or their parents (in minors) were
obtained, before collection of clinical samples).
Serosurveillance
All serum samples were tested for the presence of dengue
specific IgM and IgG antibodies using the dengue dipstick
ELISA kit developed in our laboratory [11]. Briefly, projections of nitrocellulose (NC) comb (Advanced Microdevices, Ambala, India) were coated with sucrose gradient
purified cell culture adapted DEN 1–4 cocktail antigen.
For the detection of IgM antibodies, IgG antibodies were
first removed from patient sera following adsorption with
Protein 'A' derived from Staphylococcus aureus Cowan I,
where as for detection of IgG antibodies, patient sera were
used as such without any pre treatment. Goat anti-human
IgM horshradish peroxidase (HRP) and goat anti-human
IgG HRP conjugate (Sigma, USA) were used as secondary
antibodies for the detection of IgM and IgG antibodies,
respectively. The reaction was finally developed by dipping the projections in an insoluble substrate solution
(phosphate citrate buffer pH 4.5, containing 3, 3'diamino benzidine (DAB), 4-chloro-1-napthol and
hydrogen peroxide). The results were visually recorded as
filled brown dots, indicative of the presence of dengue
specific antibodies.
RT-PCR
The identification of the virus isolates obtained from the
clinical samples was carried out by RT-PCR followed by
nested PCR by demonstrating the presence of virus specific RNA employing dengue group-specific as well as
serotype-specific primers targeting C-prM gene junction
following the protocol of Lanciotti et al, 1992, with slight
modifications [6,23]. Briefly, viral RNA was extracted
from 140 μl of serum samples using QIAamp viral RNA
mini kit (Qiagen, Germany) in accordance with the manufacturer's instructions and finally RNA was eluted in 50
μl of nuclease free water. The complementary DNA
(cDNA) was synthesized in a 10 μl reaction volume with
RT mix comprising of 5X-RT buffer, dNTPs, RNasin® ribonuclease inhibitor and Moloney murine leukemia virus
reverse transcriptase (MMLV-RT) (Promega, USA) with
dengue virus complex specific antisense primer (D2)
(Operon, Germany). The RT mix was incubated for 1 h at
37°C, before heating the reaction for 5 min at 99°C to
inactivate the MMLV-RT enzyme. The amplification of

http://www.virologyj.com/content/3/1/55

cDNA was carried out in a total volume of 50 μl with PCR
mix containing 10× PCR buffer, 25 mM MgCl2, NTPs, TaqDNA polymerase (Promega, USA), using dengue virus
complex specific sense primer (D1), (Operon, Germany)
in a thermal cycler (BioRad, USA). The thermal profile of
the PCR reaction was- initial denaturation at 95°C for 2
min., followed by 35 cycles of denaturation at 95°C for 1
min, annealing at 54°C for 1 min, extension at 72°C for
2 min and final extension at 72°C for 10 min. The PCR
products were gel purified from 1.2% agarose gel using
the QIAquick PCR purification kit (Qiagen, Germany).
Virus isolation
Isolation of viruses from the acute phase viraemic samples
was also attempted in the C6/36 cells, following the
standard virus adsorption protocol [12]. Briefly, 500 μl of
plasma samples (diluted 1:10 in sterile phosphate buffered saline) was inoculated onto confluent monolayers of
C6/36 cells in 25 cm2 tissue culture flasks. The inoculum
was incubated for 2 h before being replenished by 10 ml
of fresh maintenance medium (Eagles minimum essential
medium (EMEM, Sigma) with 10% foetal bovine serum
(FBS, Sigma). Suitable healthy cell controls were also kept
along side. The cells were then incubated at 32°C and
observed microscopically daily for the appearance of cytopathic effects (CPE), if any. The supernantants of infected
cell culture were collected on the 6th – 7th post infection
day (PID) and analysed for the presence of virus. Invariably, three subsequent serial blind passages were given in
each case.
Sequencing reaction
Double stranded sequencing of the C-prM gene junction
was performed on an ABI 310 sequencer (Applied Biosystems, USA), employing Big dye terminator cycle sequencing ready reaction kit. Briefly, 2 μl (approximately 25 ng)
of purified PCR product was mixed with 3.2 pmol of
respective primer and a reaction mixture containing the
four dye-labeled dideoxynucleotide terminators. Cycle
sequencing was then performed as follows: 25 cycles at
96°C for 30 sec, 50°C for 1 min and 60°C for 4 min. The
reaction mixture was purified by ethanol precipitation
and the DNA was vacuum dried. The DNA pellet was
resuspended in 10 μl of template suppression reagent
(TSR) and preheated before loading on to the DNA
sequencer.
Sequence analysis
The nucleotide sequences were edited and analysed by
using the EditSeq and MegAlign modules of the Lasergene-5 software package (DNASTAR Inc, USA). Multiple
sequence alignments was done employing CLUSTALW
version 1.83 [24]. The phylogenetic tree was constructed
by the Neighbour-joining method using MEGA v2.1 pro-

Page 9 of 10
(page number not for citation purposes)

Virology Journal 2006, 3:55

gramme [25]. The tree topologies were evaluated using
10,000 replicates of the data set.

http://www.virologyj.com/content/3/1/55

13.
14.

Competing interests
The author(s) declare that they have no competing interests.

15.

Authors' contributions
PKD conceived the study, carried out the sequencing
experiments and phylogenetic analysis and drafted the
manuscript. MMP carried out the RT-PCR experiments, PS
carried out the virus isolation experiments, AA carried out
the clinical sample processing, immunoassays and
sequence analysis study. CPS and KNT were responsible
for collection and storage of clinical samples and meticulous collection of case history. AMJ and KS liaison
between MCD and DRDE and coordinated this study.
PVLR helped out to design and draft the manuscript and
also revised it critically. All authors read and approved the
final manuscript.

16.
17.
18.
19.

20.
21.

Acknowledgements
The authors are thankful to Defence Research and Development Organization for providing necessary facility and financial grant for this study. The
authors are thankful to Dr Shri Prakash, Dr B. D. Parashar, Dr N. Gopalan
of Division of Entomology, DRDE for their support in sample collection and
Shri N. K. Tripathi, Shri Ambuj and Ms S. Agarwal for their technical support during this study.

22.

23.

References
1.
2.
3.
4.
5.
6.
7.

8.
9.
10.

11.

12.

World Health Organization: Dengue and dengue haemorrhagic
fever. Fact sheet 2002, 117:.
Henchal EA, Putnak JR: The dengue viruses. Clin Microbiol Rev
1990, 3:376-96.
Mc Bride WJH, Bielefeldt-Ohmann H: Dengue viral infections;
pathogenesis and epidemiology. Microbes and Infect 2000,
2:1041-50.
Dar L, Broor S, Sengupta S, Xess I, Seth P: The first major outbreak of dengue haemorrhagic fever in Delhi, India. Emerg
Infect Dis 1999, 5:589-90.
Parida MM, Dash PK, Upadhyay C, Saxena P, Jana AM: Serological
and Virological investigation of an outbreak of dengue fever
in Gwalior, India. Ind J Med Res 2002, 116:248-54.
Dash PK, Saxena P, Abhyankar A, Bhargava R, Jana AM: Emergence
of dengue virus type-3 in northern India. Southeast Asian J Trop
Med Public Health 2005, 36:25-32.
Kumar M, Pasha ST, Mittal V, Rawat DS, Arya SC, Agarwal N, Bhattacharya D, Lal S, Rai A: Unusual emergence of Guate98-like
molecular subtype of DEN-3 during 2003 dengue outbreak in
Delhi. Dengue Bull 2004, 28:161-7.
Monath TP: Dengue: The risk to developed and developing
countries. Proc Natl Acad Sci 1994, 91:2395-400.
Guzman MG, Kouri G: Advances in dengue diagnosis. Clin Diagn
Lab Immunol 1996, 3:621-7.
Wu SJL, Hanson B, Paxton H, Nisalak A, Vaughn DW, Rossi C, Henchal EA, Porter KR, Watts DM, Hayes CG: Evaluation of a dipstick
enzyme linked immunosorbent assay for detection of antibodies to dengue virus. Clin Diagn Lab Immunol 1997, 4:452-7.
Parida MM, Upadhyay C, Saxena P, Dash PK, Jana AM, Seth P: Evaluation of a Dipstick ELISA and a rapid Immunochromatographic test for diagnosis of dengue virus infection. Acta
Virologica 2000, 45:299-304.
Yamada K, Takasaki T, Nawa M, Kurane I: Virus isolation as one of
the diagnostic methods for dengue virus infection. J Clin Virol
2002, 24:203-9.

24.

25.

Leitmeyer KC, Vaughn DW, Watts DM, Salas R, Chacon de IV, Ramos
C, Rico-Hesse R: Dengue virus structural differences that correlate with pathogenesis. J Virol 1999, 73:4738-4747.
Dash PK, Parida MM, Saxena P, Kumar M, Rai A, Pasha ST, Jana AM:
Emergence and continued circulation of Dengue-2 (Genotype IV) virus strains in northern India. J Med Virol 2004,
74:314-22.
Deubel V, Nogueira RM, Drouet MT, Zeller H, Reynes JM, Ha DQ:
Direct sequencing of genomic cDNA fragments amplified by
the polymerase chain reaction for molecular epidemiology
of dengue-2 viruses. Arch Virol 1993, 129:197-210.
Lanciotti RS, Lewis JG, Gubler DJ, Trent DW: Molecular evolution
and epidemiology of dengue-3 viruses. J Gen Virol 1994,
75:65-75.
Uzcategui NY, Comach G, Camacho D, Cuello de Uzcategui R, Holmes EC, Gould EA: Molecular epidemiology of dengue virus
type 3 in Venezuela. J Gen Virol 2003, 84:1569-75.
Messer WB, Gubler DJ, Harris E, Sivananthan K, de Silva AM: Emergence and global spread of a dengue serotype 3, subtype III
virus. Emerg Infect Dis 2003, 9:800-9.
Padbidri VS, Mahadev PVM, Thakare JP, Pant U, Ilkal MA, Varghese G,
Joshi GD, Mavale MS, Paramasivan R, Athavale SS, Gaikwad DL, Rao
TLG: Virological and entomological investigations of an outbreak of dengue fever in Dhule district, Maharashtra. Indian J
Med Microbiol 1996, 14:25-32.
Rahman M, Rahman K, Siddque AK, Shoma S, Kamal AHM, Ali KS,
Nisaluk AM, Breiman RF: First outbreak of Dengue hemorrhagic fever, Bangladesh. Emerg Infect Dis 2002, 8:738-40.
Messer WB, Vitarana U, Sivananthan K, Elvtigala J, Preethimala LD,
Ramesh R, Withana N, Gubler DJ, de Silva AM: Epidemiology of
Dengue in Sri Lanka before and after the emergence of epidemic dengue hemorrhagic fever. Am J Trop Med Hyg 2002,
66:765-73.
Rico-Hesse R, Harrison LM, Salas RA, Tovar D, Nisalak A, Ramos C,
Boshell J, de Mesa MT, Nogueira RMR, da Rosa AT: Origins of dengue type-2 viruses associated with increased pathogenicity in
the Americas. Virol 1997, 230:244-51.
Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV: Rapid
detection and typing of dengue viruses from clinical samples
by using reverse transcriptase-polymerase chain reaction. J
Clin Microbiol 1992, 30:545-51.
Thompson JD, Higgins DG, Gibson TJ: Clustal W: Improving the
sensitivity of progressive multiple sequence alignment
through sequence weighting, position specific gap penalties
and weight matrix choice. Nucleic Acid Res 1994, 22:4673-80.
Kumar S, Tamura K, Jakobsen IB, Nei M: MEGA2: Molecular evolutionary genetic analysis software.
Bioinformatics 2001,
17:1244-5.

Publish with Bio Med Central and every
scientist can read your work free of charge
"BioMed Central will be the most significant development for
disseminating the results of biomedical researc h in our lifetime."
Sir Paul Nurse, Cancer Research UK

Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central
yours — you keep the copyright

BioMedcentral

Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp

Page 10 of 10
(page number not for citation purposes)

</pre>
</body>
</html>
